Day: December 26, 2019

SHENZHEN, China, Dec. 26, 2019 (GLOBE NEWSWIRE) — ATIF Holdings Limited (“ATIF”, or the “Company”), a company providing financial consulting services to small and medium-sized enterprises in Asia, today announced that the Company, through its wholly-owned Hong Kong incorporated subsidiary ATIF Limited (“ATIF HK”), entered into an Agreement for Sale and Purchase in Respect of Shares and Subordinated Loan of Sinofortune Securities Limited (the “Agreement”) with Sinofortune Financial Holdings (BVI) Limited on December 20, 2019.Sinofortune Financial Holdings (BVI) Limited is a private limited company incorporated in the British Virgin Islands (the “Seller”) and a wholly-owned subsidiary of Sinofortune Financial Holdings Limited (the “Listco”), which is a public...

COLORADO SPRINGS, CO, Dec. 26, 2019 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — Gold Resource Corporation (NYSE American: GORO) (the “Company”) declares its monthly instituted dividend of one-third of a cent per common share for December 2019 payable on January 23, 2020 to shareholders of record as of January 13, 2020.  Gold Resource Corporation is a gold and silver producer, developer and explorer with operations in Oaxaca, Mexico and Nevada, USA. The Company has returned $113 million to its shareholders in consecutive monthly dividends since July 2010 and offers its shareholders the option to convert their cash dividends into physical gold and silver and take delivery.  For more information on Gold Resource Corporation’s physical dividend program, visit the Company website at http://www.goldresourcecorp.com/gold-silver-dividends.php.  Dividends...

Prescription Drug User Fee Act (PDUFA) target action date set for June 2, 2020MORRIS PLAINS, N.J., Dec. 26, 2019 (GLOBE NEWSWIRE) — Immunomedics, Inc. (NASDAQ: IMMU) (“Immunomedics” or the “Company”), a leading biopharmaceutical company in the area of antibody-drug conjugates, today announced that the U.S. Food and Drug Administration (FDA) has accepted for filing the Company’s Biologics License Application (BLA) seeking accelerated approval of sacituzumab govitecan for the treatment of patients with metastatic triple-negative breast cancer (mTNBC) who have received at least two prior therapies for metastatic disease, as a complete class 2 response. The PDUFA target action date of the resubmitted BLA is June 2, 2020.“We are pleased that the FDA has accepted our resubmission, which was a top priority...

Las Vegas, NV, Dec. 26, 2019 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — Hemp, Inc. (OTC PINK: HEMP), a global leader in the industrial hemp industry with bi-coastal processing centers, including the largest multipurpose industrial hemp processing facility in the western hemisphere, announced today news coverage in Havasu News, a leading source for news, sports and opinions in Lake Havasu City, Arizona.The published article features an interview with Bruce Perlowin, CEO of Hemp, Inc. regarding the kins communities, specifically focused on Hemp, Inc.’s kins community, Veterans Village, in Golden Shores, Arizona.Veterans Village will be the first kins community focused on rehabilitating veterans by providing them a place to live, a way to make money, and access to various health professionals. In the interview,...

Patient screening positions Company for completion of a short clinical trialSignificant market demand for oral drugs in Inflammatory Bowel DiseaseBusiness development meetings scheduled during 2020 J.P. Morgan Healthcare ConferenceBEVERLY, Mass., Dec. 26, 2019 (GLOBE NEWSWIRE) — Innovation Pharmaceuticals (OTCQB:IPIX) (“the Company”), a clinical stage pharmaceutical company, is pleased to announce that patient screening for its Phase 1 trial to investigate the use in healthy volunteers of delayed release tablets for colonic delivery of oral Brilacidin for treating Ulcerative Colitis, a chronic form of Inflammatory Bowel Disease (IBD), is expected to commence in early January.Approximately two weeks ago, the United Kingdom’s Medicines and Healthcare products Regulatory Agency granted the Company approval to start...

CRANBURY, N.J., Dec. 26, 2019 (GLOBE NEWSWIRE) — Outlook Therapeutics, Inc. (NASDAQ: OTLK) (the “Company”), a late clinical-stage biopharmaceutical company working to develop the first FDA-approved ophthalmic formulation of bevacizumab for use in retinal indications, today announced that it has completed the previously announced warrant restructuring.Effective December 23, 2019, with consent of the required holders of the Outlook Therapeutics warrants issued in the Company’s April 2019 underwritten public offering (the “April Warrants”), the Company amended the April Warrants to reduce the exercise price to $0.232 per share and allow for the immediate cashless exercise of the April Warrants.  In addition, the expiration date for all of the April Warrants was changed...

NEW YORK, NY, Dec. 26, 2019 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the“Company”), a revenue generating Company that operates through the development, distribution, and licensing of proprietary products as well as the evaluation of potential acquisition opportunities and equity investments, today announced it has received Tens of Thousands of Dollars worth of Purchase Orders from multiple International / Kosher Distributors. These Purchase Orders have been received by the Company, as a result of the Exhibitor Booth (# 7095) that it operated at Kosherfest 2019 – which took place on November 12-13, 2019 in Secaucus, New Jersey.  The Company has already received payment(s) and shipped product, concerning a substantial portion of...

OTTAWA, Dec. 26, 2019 (GLOBE NEWSWIRE) — HEXO Corp. (“HEXO” or the “Company”) (TSX: HEXO; NYSE: HEXO) today announced it has entered into a definitive agreement with institutional investors for the purchase and sale of 14,970,062 common shares at an offering price of US$1.67 per share for gross proceeds of US$25.0 million before deducting fees and other estimated offering expenses, pursuant to a registered direct offering (the “Offering”). The Company has also agreed to issue to the investors common share purchase warrants to purchase 7,485,032 common shares of the Company. The warrants will have a five year-term and an exercise price of US$2.45 per share.The Company expects to use the net proceeds from the Offering for working capital and other general corporate purposes, including funding...

CALGARY, Alberta, Dec. 26, 2019 (GLOBE NEWSWIRE) — News Release – TC Energy Corporation (TSX, NYSE: TRP) (TC Energy or the Company) announced today that it has entered into an agreement to sell a 65 per cent equity interest in the Coastal GasLink Pipeline Project (Coastal GasLink or the Project) to KKR and Alberta Investment Management Corporation (AIMCo) on behalf of certain AIMCo clients. Concurrent with the completion of the sale, TC Energy expects that Coastal GasLink will enter into a secured project financing construction credit facility with a syndicate of banks to fund up to 80 per cent of the Project during construction. Both transactions are expected to close in the first half of 2020, subject to customary regulatory approvals and consents, including the consent of LNG Canada.“The partial monetization of Coastal...

GRAPEVINE, Texas, Dec. 26, 2019 (GLOBE NEWSWIRE) — Don’t let the holidays end without unwrapping the gift you really wanted. Take advantage of GameStop’s annual Winter Sale, beginning Dec. 26 through Jan. 1. See Winter Sale Ad.Have too many gift cards and can’t decide how to maximize their value? See below for a sample of Winter Sale deals that customers can expect to find at GameStop’s more than 3,700 stores or by visiting www.GameStop.com.Video Game Consoles:Sony PS4 1TB System Bundle with God of War, Horizon Zero Dawn and The Last of Us Remastered: $249.99 ($50 savings) – valid until Dec. 28Xbox One X Console Limited Edition 1TB Bundle with NBA 2K20: $349.99 ($150 savings) – valid until Dec. 29Software:NBA2K20: $29.99Ghost Recon Breakpoint: $19.99 (66% savings)Overwatch Legendary Edition (Switch...